Hurtado-Lorenzo discusses trial data showing time-restricted feeding in Crohn’s disease results in weight loss, symptom improvement, and microbiome changes.
Crohn's & Colitis Foundation
Latest Content
Hurtado-Lorenzo explains the growing interest in meal timing as a potential lifestyle intervention for Crohn’s and recent trial data supporting its utility in this patient population.
Wingate reviews new Crohn’s and Colitis Foundation data on insurance barriers faced by young adults with IBD and offers practical insights for overcoming these challenges.
The FDA has approved several biologics in recent years for the treatment of patients with inflammatory bowel disease.
Advertisement
Advertisement
Trending on HCPLive
1
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5